#United States #San Diego #OnPoint AR-AI #AR Spine System #Philipp Lang

OnPoint AR-AI to Present at the 2025 Musculoskeletal Conference

OnPoint AR-AI, a groundbreaking consortium of augmented reality (AR) technology firms, is poised to make a significant impact at the 2025 Canaccord Genuity Musculoskeletal Conference. The event will unfold on March 10, 2025, at the Westin San Diego Gaslamp, where Dr. Philipp Lang, the company's Chairman and CEO, alongside Grace Connelly, CFO, will represent OnPoint during their presentation scheduled for 11:30 AM Pacific Time.

The innovative prowess of OnPoint AR-AI is encapsulated in its OnPoint AR Spine System, a system that is transforming spinal surgery. This sophisticated technology superimposes virtual surgical aids and implants directly into the surgeon's line of sight using advanced optical head-mounted display technology. Surgeons have commended this system for its user-friendly interface and intuitive operation, making it a viable tool in real-time surgical environments.

One of the most remarkable aspects of the OnPoint AR Spine System is its versatility. It operates as an open-platform solution that is compatible with implants from major manufacturers, ensuring that surgeons do not need to alter their existing practices. This adaptability, coupled with its cost-effective nature, presents a compelling alternative to more traditional robotic surgical systems.

Research and cadaver studies have highlighted the superior precision of the OnPoint AR Spine System. It has been demonstrated to exceed the accuracy of existing navigation and robotic systems by margins ranging from 2 to 5 times, while also maintaining statistical significance across various comparisons, according to findings presented at the 2023 Congress of Neurological Surgeons. This level of accuracy enhances the overall surgical experience, reducing the risks involved in complex procedures.

Dr. Philipp Lang emphasized the economic benefits of OnPoint's technology, stating, "OnPoint offers an attractive financial profile for hospitals and ASC's using its rapidly accretive, exceptionally accurate, and cost-effective technology. It is a modular platform technology programmed for brisk expansion..." The company’s extensive intellectual property portfolio, valued at over $250 million, reinforces its position within the industry, providing secure innovative avenues for future development.

About OnPoint AR-AI
OnPoint comprises several privately-held medical technology companies, including OnPoint Surgical, OnPoint Medical, OnPoint Knee, OnPoint Hip, and OnPoint Sports. Each entity focuses on utilizing augmented reality and machine learning to refine a variety of surgical interventions. Their ambitions stretch across both neurosurgical and orthopedic realms as well as initiatives in robotic surgery and beyond.

The OnPoint technology is not only innovative but also protected by a robust portfolio of over 50 granted patents across the U.S., China, and the EU, establishing a solid foundation for their AR guidance applications in surgical settings. The companies are actively engaged in expanding their technology for multiple other clinical applications, positioning themselves as leaders in medical advancements.

To learn more about OnPoint AR-AI and their groundbreaking AR technology, please visit www.onpointar.ai.